Literature DB >> 33065114

The alpha-1,2 fucosylated tubule system of DU145 prostate cancer cells is derived from a partially fragmented Golgi complex and its formation is actin-dependent.

Domenico Nolfi1, Antonietta Capone2, Floriana Rosati3, Cinzia Della Giovampaola2.   

Abstract

In previous work, we showed that highly proliferative cells and cancer cells, but not cells with normal growth rate, have tubules rich in alpha-1,2 fucosylated epitopes that extend radially from the nucleus to the cell periphery and form an unusual uptake system. The importance of alpha-1,2 fucosylation in forming tubules was demonstrated by proving that down-regulating the two corresponding fucosyltransferases (FUT1 and FUT2) causes tubule fragmentation. Here, we present evidence that in the prostate cancer cell line DU145, the tubules arise in actively growing cells from vesicles in the medial and trans elements of a partially fragmented Golgi complex, while in not actively growing cells the tubules become completely independent from the Golgi complex. Formation and elongation of the tubules proved to depend on the actin cytoskeleton, since the alpha-1,2 fucosylated protein(s) segregate with the cytoskeleton proteins, and not in the membrane fraction, as do the Golgi markers and other fucosylated proteins, while depolymerization of the actin filaments causes tubule fragmentation and shifting of the alpha-1,2 fucosylated proteins into the membrane fraction.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DU145 cells; Golgi complex fragmentation; Lotus lectin; Proliferation; alpha1,2 fucosylation

Year:  2020        PMID: 33065114     DOI: 10.1016/j.yexcr.2020.112324

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

Review 1.  Adaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis.

Authors:  Sarah Bui; Isabel Mejia; Begoña Díaz; Yanzhuang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-10

2.  Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.

Authors:  Tomoaki Furuta; Tatsuya Oda; Kayo Kiyoi; Ozawa Yusuke; Sota Kimura; Ko Kurimori; Yoshihiro Miyazaki; Yang Yu; Kinji Furuya; Yoshimasa Akashi; Osamu Shimomura; Hiroaki Tateno
Journal:  Cancer Sci       Date:  2021-06-29       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.